Cargando…
SARS-CoV-2 antibody seroprevalence in patients receiving dialysis in the USA
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7518795/ https://www.ncbi.nlm.nih.gov/pubmed/32987009 http://dx.doi.org/10.1016/S0140-6736(20)32006-7 |
_version_ | 1783587454141333504 |
---|---|
author | Flower, Barnaby Atchison, Christina |
author_facet | Flower, Barnaby Atchison, Christina |
author_sort | Flower, Barnaby |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7518795 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-75187952020-09-28 SARS-CoV-2 antibody seroprevalence in patients receiving dialysis in the USA Flower, Barnaby Atchison, Christina Lancet Comment Elsevier Ltd. 2020 2020-09-25 /pmc/articles/PMC7518795/ /pubmed/32987009 http://dx.doi.org/10.1016/S0140-6736(20)32006-7 Text en © 2020 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Comment Flower, Barnaby Atchison, Christina SARS-CoV-2 antibody seroprevalence in patients receiving dialysis in the USA |
title | SARS-CoV-2 antibody seroprevalence in patients receiving dialysis in the USA |
title_full | SARS-CoV-2 antibody seroprevalence in patients receiving dialysis in the USA |
title_fullStr | SARS-CoV-2 antibody seroprevalence in patients receiving dialysis in the USA |
title_full_unstemmed | SARS-CoV-2 antibody seroprevalence in patients receiving dialysis in the USA |
title_short | SARS-CoV-2 antibody seroprevalence in patients receiving dialysis in the USA |
title_sort | sars-cov-2 antibody seroprevalence in patients receiving dialysis in the usa |
topic | Comment |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7518795/ https://www.ncbi.nlm.nih.gov/pubmed/32987009 http://dx.doi.org/10.1016/S0140-6736(20)32006-7 |
work_keys_str_mv | AT flowerbarnaby sarscov2antibodyseroprevalenceinpatientsreceivingdialysisintheusa AT atchisonchristina sarscov2antibodyseroprevalenceinpatientsreceivingdialysisintheusa |